8 research outputs found

    c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study

    Get PDF
    INTRODUCTION: c-erbB2 (also known as HER-2/neu) and topoisomerase IIα are frequently overexpressed in breast cancer. The aim of the study was to analyze retrospectively whether the expression of c-erbB2 and topoisomerase IIα protein influences the long-term outcome of patients with primary breast cancer. METHODS: In this study c-erbB2 and topoisomerase IIα protein were evaluated by immunohistochemistry in formalin-fixed paraffin-embedded tissue from 225 samples of primary breast cancer, obtained between 1986 and 1998. The prognostic value of these markers was analyzed. RESULTS: Of 225 primary breast tumor samples, 78 (34.7%) showed overexpression of either c-erbB2 (9.8%) or topoisomerase IIα protein (24.9%), whereas in 21 tumors (9.3%) both proteins were found to be overexpressed. Patients lacking both c-erbB2 and topoisomerase IIα overexpression had the best long-term survival. Overexpression of either c-erbB2 or topoisomerase IIα was associated with shortened survival, whereas patients overexpressing both c-erbB2 and topoisomerase IIα showed the worst disease outcome (P < 0.0001). Treatment with anthracyclines was not capable of reversing the negative prognostic impact of topoisomerase IIα or c-erbB2 overexpression. CONCLUSION: The results of this exploratory study suggest that protein expression of c-erbB2 and topoisomerase IIα in primary breast cancer tissues are independent prognostic factors and are not exclusively predictive factors for anthracycline response in patients with primary breast cancer

    Otimização de imagens mamográficas Optimization of mammographic images

    No full text
    OBJETIVO: Este trabalho tem como objetivo a otimização de imagens mamográficas, com consideráveis reduções de doses. MATERIAIS E MÉTODOS: Neste estudo o feixe de raios-X foi calibrado para cada tensão (kVp), de modo a determinar a melhor combinação de kVp e mAs que irá proporcionar uma densidade ótica (DO) em torno de 1.0 acima da base mais véu do filme utilizado. RESULTADOS: Serão discutidas questões sobre os métodos empregados para a seleção de parâmetros de exposição do feixe de raios-X, seleção da melhor imagem utilizando o método de avaliação gradativa visual, comparações entre as doses e carga do tubo (kVp × mAs) proporcionadas pelas técnicas determinadas neste estudo e pelas utilizadas na rotina clínica do Serviço de Diagnóstico por Imagem do Hospital das Clínicas da Faculdade de Medicina de Botucatu. Neste estudo foram obtidas imagens radiográficas de mama de excelente qualidade, com redução de dose e carga de tubo, respectivamente, de 36,8% e 46,2%, quando comparadas com a técnica utilizada pela rotina clínica da instituição. CONCLUSÃO: Esta pesquisa vem contribuir com a otimização da relação risco-benefício para o paciente e custo-benefício para a instituição.<br>OBJECTIVE: The aim of this study is the optimization of mammographic images with a considerable radiation dose reduction. MATERIALS AND METHODS: In the present study the X-ray beam was calibrated for each tension (kVp), aiming at determining the best combination between kVp and mAs, resulting in optical densities of about 1.0 above the base-plus-fog density. RESULTS: This study will bring into question the methods for X-ray beam calibration, the choice of the best image by means of visual grading analysis, comparisons between doses and tube load (kVp × mAs) delivered by the techniques described in this study and by those adopted in the clinical routine at Service of Diagnostic Imaging of Faculdade de Medicina de Botucatu Clinics Hospital, Botucatu, SP, Brazil. Excellent breast radiographic images have been obtained with doses and tube loads reduction of respectively 36.8% and 46.2% in comparison to those employed in our institutions' clinical routine. CONCLUSION: This study is a contribution to the optimization of the risk-benefit ratio for patients and cost-benefit ratio for the institution

    Substanzen mit dämpfender Wirkung auf das ZNS

    No full text

    Literatur

    No full text
    corecore